Achieving Red Blood Cell Transfusion Independence News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Efficacy of Imetelstat in Achieving Red Blood Cell Transfusion Independence (RBC-TI) across Different Risk Subgroups in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis-Stimulating Agents (ESAs) in IMerge Phase 3 Study

Amer Zeidan, MBBS, MHS, presents data from the IMerge phase 3 study on the efficacy of imetelstat in achieving red blood cell transfusion independence across different risk subgroups in patients with lower-risk myelodysplastic syndromes relapsed/refractory to erythropoiesis-stimulating agents.

San diegoUnited statesSamer zeidanInternational prognostic scoring systemAchieving red blood cell transfusion independenceDifferent risk subgroupsLower risk myelodysplastic syndromesErythropoiesis stimulating agentsPartnership withMyelodysplastic syndromeImerge studyImerge trialImerge phase 3 studyLower risk mdsLower risk myelodysplastic syndromeRed blood cell transfusion independence

Geron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS

Geron IMerge Phase 3 Presentations at Upcoming ASH Annual Meeting Reinforce Significant Durability and Breadth of Effect of Imetelstat in Lower Risk MDS
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoOptum clinformaticsFaye fellerEuropean medicines agencyEuropean unionGeron corporation nasdaqDrug administrationInternational prognostic scoring systemMoffitt cancer centerExchange commissionMalignant hematology departmentAmerican society of hematologyLarge us health insurance claims databaseMeeting reinforce significant durabilityLower risk